Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer identifies potential immunotherapy target antigens by Ternette, N, Olde Nordkamp, M, Muller, J, Anderson, A, Nicastri, A, Hill, A, Kessler, B, Li, D

Development of a T cell receptor mimic antibody against wild-type p53 for cancer immunotherapy by Li, D, Bentley, C, Anderson, A, Wiblin, S, Cleary, K, Koustoulidou, S, Hassanali, T, Yates, J, Greig, J, Olde Nordkamp, M, Trenevska, I, Ternette, N, Kessler, B, Cornelissen, B, Cragg, M, Banham, A